Learning outcomes
By the end of this lesson you should be able to: name the intravenous induction agents with their doses and cardiovascular and respiratory effects, and choose the right one for a shocked, head-injured or asthmatic patient; define minimum alveolar concentration and list the factors that change it; explain context-sensitive half-time and apply it to choosing an opioid for a short versus a long case; describe the mechanism, duration and reversal of depolarising and non-depolarising neuromuscular blockers; and monitor depth of block with a train-of-four stimulator.
Prerequisites
Lesson 1 (Acute medicine and applied physiology) and the MBBS pharmacology course: receptors, receptor agonists and antagonists, first-pass metabolism, volume of distribution and clearance. You must be comfortable with the idea that the clinical duration of an infused drug is governed by equilibration into and out of peripheral tissue compartments.
The big idea
Anaesthesia is not sleep induced by one drug; it is the reversible suspension of awareness, memory, movement and pain, delivered as a combination. The organising concept of this lesson is context sensitivity: where a drug goes after it enters the blood determines how long its effect lasts once the infusion stops. Fentanyl is a short-acting drug for a 20-minute operation and a long-acting one for a four-hour case. The same idea explains why suxamethonium wears off in five minutes while rocuronium takes forty, and why the choice of reversal (neostigmine or sugammadex) depends on which blocker was given.
Intravenous induction agents
| Agent | Induction dose (IV) | Mechanism | Principal effects and cautions |
|---|---|---|---|
| Propofol | 1.5–2.5 mg/kg; reduce to about 1 mg/kg in the frail elderly | GABA-A receptor agonist | Hypotension (vasodilatation plus myocardial depression), apnoea, pain on injection; anticonvulsant; lowers intracranial and intraocular pressure. Propofol infusion syndrome with prolonged high-dose infusion: lactic acidosis, rhabdomyolysis, lipaemia |
| Thiopental | 3–5 mg/kg | GABA-A agonist (barbiturate) | Rapid reliable induction with profound respiratory depression and negative inotropy; historically the agent for rapid-sequence induction in the shocked patient and still used in status epilepticus in some protocols |
| Etomidate | 0.3 mg/kg | GABA-A modulation (imidazole) | Cardiostable — the classic choice in the shocked or elderly patient — but causes adrenocortical suppression (inhibition of 11-beta-hydroxylase) even after one dose, myoclonus, pain on injection and thrombophlebitis |
| Ketamine | 1–2 mg/kg IV, 10 mg/kg IM | NMDA-receptor antagonist | Dissociative anaesthesia with sympathomimetic action: preserves blood pressure, bronchodilates (useful in severe asthma), but raises intracranial and intraocular pressure, causes hypersalivation and emergence delirium; a controlled drug |
| Midazolam | 0.05–0.1 mg/kg titrated | Benzodiazepine acting at GABA-A | Anxiolysis and antegrade amnesia; synergistic respiratory depression with opioids; prolonged effect in the elderly because of an active metabolite; reversed by flumazenil, which is short-acting so relapse occurs |
Choose from the physiology, not from habit. The shocked trauma patient needs etomidate or ketamine because propofol will drop the vascular resistance and cardiac output maintaining the pressure. The patient with a head injury needs propofol or thiopental because they lower cerebral metabolic rate and intracranial pressure, and must never receive ketamine. The severe asthmatic needs ketamine for its bronchodilation. Induction doses must also be reduced in the elderly, the premedicated and the recently opioid-dosed patient, because the clinical end point — loss of response to verbal command and loss of the eyelash reflex — arrives earlier than the syringe calculation suggests.
Watch outApnoea on induction is expected, and failure to recognise it in time is a recognised cause of perioperative hypoxic arrest. Preoxygenate for three minutes of tidal breathing (or eight vital-capacity breaths), and have suction, a working bag-mask, a supraglottic airway and an assistant present before giving the first drug. Never induce a patient alone.
Inhalational agents and MAC
| Agent | MAC in oxygen | Blood:gas solubility | Practical notes |
|---|---|---|---|
| Sevoflurane | About 2.0% | 0.65 (low) | Pleasant and non-pungent, so the standard agent for inhalational induction; compound A accumulation at low fresh-gas flows |
| Isoflurane | About 1.15% | 1.4 | Pungent, vasodilator, the workhorse maintenance agent and cheap; coronary steal debate now largely discounted |
| Desflurane | 6.0–6.6% | 0.42 (very low) | Very fast emergence but pungent and airway-irritant (coughing, laryngospasm, sympathetic surge); needs a heated pressurised vaporiser |
| Nitrous oxide | About 104% (incomplete at 1 atm) | 0.47 | Good analgesia but weak potency; diffuses into air-filled spaces (contraindicated in bowel obstruction, pneumothorax and middle-ear surgery); oxidises cobalt in vitamin B12 metabolism (megaloblastic change with prolonged exposure); causes diffusion hypoxia on abrupt withdrawal |
| Xenon | About 0.7% | 0.014 | Rapid, cardiostable and almost no emergence delay; expensive and not widely available |
Two gas properties govern speed. Solubility governs uptake: an agent with low blood:gas solubility (desflurane, xenon) is taken up slowly from alveolus into blood, so the alveolar fraction rises quickly and induction and emergence are fast. The second is the concentration effect and its companion, the second-gas effect: the higher the inspired concentration of a gas, the faster its alveolar concentration rises, and a rapidly taken-up gas such as nitrous oxide accelerates uptake of concurrently administered agents. This is why nitrous oxide was used to speed induction in the era of halothane.
NoteMAC is a potency measure, not a safety measure. MAC falls with advanced age (up to 30% by age 80), hypothermia, pregnancy, opioids, benzodiazepines, alpha-2 agonists and neuromuscular blockade, and rises with chronic alcohol use and in young children. Movement under anaesthesia may be inadequate paralysis rather than inadequate hypnosis — check the twitch monitor before deepening the volatile.
Opioids and context-sensitive half-time
| Opioid | Typical dosing | Metabolism and duration | Context-sensitive half-time |
|---|---|---|---|
| Fentanyl | 1–2 mcg/kg IV bolus; repeat 25–50 mcg | Hepatic CYP3A4 to inactive metabolites | Short for boluses, then lengthens markedly with infusion as peripheral compartments fill — the classic example of a drug that becomes long-acting |
| Remifentanil | 0.1–0.5 mcg/kg/min titrated to stimulus | Hydrolysed by non-specific plasma and tissue esterases | Flat at about 3–4 minutes regardless of infusion length — its defining property; have other analgesia in place before stopping |
| Morphine | 0.1 mg/kg IV; oral 5–10 mg every 4 hours | Glucuronidation; morphine-6-glucuronide is an active metabolite cleared by the kidney | Long and not context-sensitive; accumulation in renal impairment gives delayed respiratory depression; histamine release causes hypotension and itch |
| Alfentanil and sufentanil | Alfentanil 10–30 mcg/kg | Hepatic, with a smaller volume of distribution than fentanyl | Shorter half-times than fentanyl at all infusion durations, so suiting infusions for stimulating surgery |
Opioids are not anaesthetics: they blunt the sympathetic response to pain and reduce the volatile requirement but do not reliably produce unconsciousness. Their predictable adverse effects are dose-dependent respiratory depression (respiratory rate falls before tidal volume), chest-wall rigidity after rapid high-dose fentanyl, nausea and vomiting, sedation, constipation, urinary retention and pruritus. Reverse with naloxone titrated in 100 microgram increments to a respiratory rate of 10–12 rather than to full arousal, because full reversal precipitates withdrawal, severe pain and a catecholamine surge with arrhythmia and pulmonary oedema. Respiratory depression returns if the antagonist is shorter-acting than the agonist — true of every opioid except remifentanil.
Neuromuscular blockade and its reversal
Muscle relaxants are neither anaesthetics nor analgesics: they facilitate intubation and relax the abdominal wall, and they paralyse a patient who may otherwise be fully awake. Peripheral nerve stimulation is mandatory whenever they are used.
| Agent | Mechanism | Dose and duration | Key clinical points |
|---|---|---|---|
| Suxamethonium | Depolarising — persistent agonist at the nicotinic receptor, causing depolarisation then desensitisation | 1–1.5 mg/kg IV; onset 30–60 s, duration 5–10 min | The only rapid-onset, short-duration blocker. Fasciculations, myalgia, a transient rise in potassium of about 0.5 mmol/L, raised intracranial and intraocular pressure, bradycardia (especially on a second dose), phase II block with repeated dosing, and it triggers malignant hyperthermia |
| Rocuronium | Non-depolarising — competitive antagonist at the receptor | 0.6 mg/kg: onset 60–90 s, 30–60 min. 1.2 mg/kg for rapid-sequence induction (onset 45–60 s) | The alternative to suxamethonium when sux is contraindicated, and reversible at any depth with sugammadex |
| Vecuronium | Non-depolarising | 0.1 mg/kg, 30–60 min | Cardiovascularly stable; historically the standard for abdominal surgery |
| Atracurium and cisatracurium | Non-depolarising | Atracurium 0.5 mg/kg; cisatracurium 0.15 mg/kg | Degrade by Hofmann elimination (spontaneous, temperature- and pH-dependent), so suited to renal and hepatic failure; atracurium releases histamine and laudanosine |
| Pancuronium | Non-depolarising | 0.05–0.1 mg/kg, long-acting | Vagolytic tachycardia; rarely used now, but a cause of residual paralysis when chosen for speed alone |
| Reversal | Mechanism | Dose | When it works and its limits |
|---|---|---|---|
| Neostigmine | Acetylcholinesterase inhibitor, raising acetylcholine to compete with the blocker at the receptor | 0.05 mg/kg (maximum 5 mg) with glycopyrrolate or atropine against muscarinic effects | Reverses non-depolarising block only, and only once some recovery has occurred (at least two twitches); its effect plateaus, so a deeply blocked patient stays paralysed |
| Sugammadex | Gamma-cyclodextrin that encapsulates rocuronium and vecuronium in plasma, forming an inactive complex excreted in urine | 2 mg/kg with two twitches; 4 mg/kg at a post-tetanic count of 1–2; 16 mg/kg for immediate reversal 3 minutes after 1.2 mg/kg rocuronium | Reverses at any depth, at the receptor-independent level, without muscarinic side effects; does not reverse suxamethonium or non-steroidal blockers, and may reduce hormonal contraceptive efficacy for a week |
A patient received suxamethonium then a rocuronium infusion for a three-hour operation, and the train-of-four count is now zero. Why is sugammadex appropriate and neostigmine not?
Worked example: one plan, one justification per drug
A 68-year-old on a beta-blocker and a statin needs a laparoscopic cholecystectomy. Preoxygenate; induce with propofol titrated to 1–1.5 mg/kg (reduced for age, fasting and beta-blockade); give fentanyl 1–2 mcg/kg as the analgesic component; intubate with rocuronium 0.6 mg/kg rather than suxamethonium, which would raise potassium and could cause dangerous bradycardia in a beta-blocked patient. Maintain with sevoflurane or a propofol infusion and build multimodal analgesia: paracetamol, local anaesthetic infiltration at the port sites, a non-steroidal anti-inflammatory drug if renal function allows, and further fentanyl guided by heart rate and pressure. Reverse with sugammadex or neostigmine plus glycopyrrolate, confirm a train-of-four ratio above 0.9, and extubate awake. The fallback if induction fails the airway is the failed-intubation drill: call for help, oxygenate with bag-mask and a supraglottic airway, and wake the patient.
Common mistakes
Watch outFull-dose propofol in a patient who is hypovolaemic, elderly, or has already had an opioid or benzodiazepine. The resulting vasodilatation is the commonest cause of avoidable perioperative hypotension and of peri-operative cardiac arrest in fit patients.
Watch outUsing ketamine where intracranial or intraocular pressure is raised — head injury, intracranial mass, open globe injury. It raises cerebral metabolic rate and intraocular pressure; equating 'cardiostable' with 'safe in everyone' is the error.
Watch outTreating suxamethonium's short duration as safety. It causes dangerous hyperkalaemia in burns after the first 24 hours (up to 60 days), spinal cord injury, stroke with paresis, prolonged immobility and muscular dystrophy, and it triggers malignant hyperthermia. Rocuronium is the appropriate substitute in every one of these.
Watch outStopping a remifentanil infusion with no other analgesia in place. Its context-insensitive ultra-short action means the analgesia ends within minutes, leaving a patient waking to severe pain and sympathetic surge. Give the non-opioid or regional component before stopping.
Watch outExtubating because the patient 'looks comfortable' without monitoring the block. Residual paralysed weakness after arrival in recovery is entirely preventable and is one of the drivers of postoperative respiratory complications; the endpoint is an objective train-of-four ratio above 0.9.
Check your understanding
Why is remifentanil ideal for a case that could end after ten minutes, but unsuitable as the sole post-operative analgesic plan?
Which induction agent would you choose for a shocked patient with a ruptured abdominal aortic aneurysm, and why not the sedating alternative most often used for induction in procedures?
A patient given a large fentanyl dose has a respiratory rate of 6 and is unrousable. Outline your management.
Multiple choice
Which induction agent is most appropriate for emergency intubation of a patient with a systolic pressure of 70 mmHg from a ruptured spleen?
Which statement about minimum alveolar concentration is correct?
Which property most clearly distinguishes remifentanil from fentanyl when given as an infusion?
A patient given rocuronium 0.6 mg/kg 45 minutes ago has two twitches on train of four with a ratio of 0.4. What is the appropriate pharmacological reversal?
In which patient is suxamethonium contraindicated?
Summary and next
Anaesthetic drugs are chosen from the physiology of the patient: etomidate or ketamine for shock, propofol or thiopental for raised intracranial pressure, rocuronium instead of suxamethonium where hyperkalaemia is a risk, remifentanil for titratable short-duration analgesia. MAC is the potency scale of the volatiles; context-sensitive half-time explains why the same fentanyl infusion is short for a 20-minute case and long for a four-hour one; and every block must be reversed to an objectively measured train-of-four ratio above 0.9.
Next: the algorithm that ties the pharmacology together — basic and advanced life support. The same drugs (adrenaline, amiodarone, naloxone) appear again, but in a sequence dictated by rhythm rather than by case, and alongside the four reversible causes the algorithm exists to treat.